Covid-19 causing turbulence for aircraft ABS Concerns are rising about a wave of defaults in the sector
Translated by Ryu Ho-joung 공개 2021-03-18 10:11:44
이 기사는 2021년 03월 18일 08:57 thebell 에 표출된 기사입니다.
The fallout from the Covid-19 pandemic on the aviation industry has chilled the aircraft asset-backed securities (ABS) market, raising concerns about a wave of defaults across the sector.Hi Air E M No.1 Co Ltd, a special purpose vehicle (SPV), failed to repay principal worth $43.2 million for the subordinate tranches of aircraft ABS notes due in February, according to sources.
The SPV was created in in the Caymans by Hi Investment & Securities, a lessor that bought two used jets made by Boeing to lease to the Dubai-based airline Emirates in 2017.
The Seoul-based brokerage firm financed the acquisition costs of the planes by issuing ABS in the domestic market, through two SPVs – Hi Air E M No.1 Co Ltd and Hi Air E M No. 2 Co Ltd – with each SPV issuing notes worth $92.65 million and $68.2 million respectively.
The senior notes issued by Hi Air E M No.1 – worth $49.45 million – were repaid in full because they were paid by lease rents. The subordinate notes were structured be repaid with proceeds from the sale of the planes. But, Emirates, which was expected to buy them from the lessor, changed its mind and canceled the purchase.
Hi Air E M No. 2, which was structured in the same way with Hi Air E M No.1, will unlikely avoid defaults on the subordinate notes, which is due on Wednesday.
“The lessor will likely try to find a new buyer for the plans after they are returned,” an industry insider said. (Reporting by Hye-rim Pi)
< 저작권자 ⓒ 자본시장 미디어 'thebell', 무단 전재, 재배포 및 AI학습 이용 금지 >
best clicks
최신뉴스 in 전체기사
-
- '대유타워 매각' 대유위니아, 새 원매자 찾기 시동
- GA '전성시대' 계속되려면
- [보험사 IFRS17 조기도입 명암]KB손보, 부채항목 개선…상품 포트폴리오 효과는 못봤다
- [보험 패러다임 시프트]삼성생명의 제3보험 공략, 'CSM 확보'에 방점
- [한화생명 글로벌 은행업 도전기]해외 진출 주역 김동원 사장, '인도네시아' 선택한 이유
- [보험 패러다임 시프트]DB손보, 선제적 대응으로 일궈낸 '이익 체력'
- [외국계 보험사는 지금]ABL생명, 보험료 감소에도 기업가치 제고…올해는 '건강보험'
- 하나저축, 분기 흑자 전환…충당금 여파는 '여전'
- 엠케이전자, '재생 본딩와이어' 공급 스타트
- [제약바이오 맨파워 분석]리가켐의 자체임상 꿈 ACB, 2조 빅딜 숨은주역 '채제욱'